Overview

nly two things are certain in life, one is that all of us will inevita­ Obly grow older, the other is that at some point during or at the end of this process we shall die. Inherent to the passage of time is a deterio­ ration in the structural and functional integrity of our bodies, this pro­ gressing to such an extent that one or more organ systems will eventu­ ally begin to fail with the continued health and well-being of the individual coming under threat. Age-associated deficiencies in the musculo-skeletal, cardiovascular, or endocrine systems producing arthri­ tis, hypertension, stroke or diabetes are all too apparent in our elderly population yet internally caused failures in the function of the nervous system provide the common, and mostly intractable, problems of memory and intellect or locomotion that face and frustrate clinicians. Perhaps the most important factor which can decide the outcome of research studies professing to examine the effects of the passage of time (i. e. the 'process of aging') on the function of the nervous system, or indeed any other organ system, is the selection of appropriate or repre­ sentative subjects for investigation. The heart of this problem lies in defining what might be considered as 'normal' aging as distinct from age-associated disease; setting the 'goal posts of normality' continues to 1 be a matter of considerable debate.

Full Product Details

Author:   David M.A. Mann
Publisher:   Chapman and Hall
Imprint:   Chapman and Hall
Edition:   1997 ed.
Dimensions:   Width: 17.80cm , Height: 1.20cm , Length: 25.40cm
Weight:   1.280kg
ISBN:  

9780412134319

ISBN 10:   0412134314
Pages:   198
Publication Date:   15 February 1997
Audience:   Professional and scholarly ,  Professional & Vocational
Format:   Hardback
Publisher's Status:   Active
Availability:   In Print  
This item will be ordered in for you from one of our suppliers. Upon receipt, we will promptly dispatch it out to you. For in store availability, please contact us.

Table of Contents

1. Introduction.- 2. Pathological Changes in the Elderly Human Brain.- 2.0. Introduction.- 2.1. Gross Changes in the Brain.- 2.2. Nerve Cell Numbers in Aging.- 2.3. Regressive Changes in Neurones with Aging.- 2.4. Senile Plaques.- 2.5. Neurofibrillary Tangles.- 2.6. Lewy Bodies.- 2.7. Hirano Bodies.- 2.8. Granulovacuolar Degeneration.- 2.9. Neuropigments.- 2.10. Other Neuronal Changes.- 2.11. Changes in Glial Cells.- 2.12. Cerebrovascular Changes.- 2.13. Brain Aging: Compensation Versus Redundancy.- 3. Pathological Changes in Neurodegenerative Disease.- 3.1. Introduction.- 3.2. The Pathological Changes of Alzheimer’s Disease.- 3.3. The Initial Site of Damage.- 3.4. The Presence of Alzheimer-type Pathology in Situations Other than AD.- 3.5. The Pathogenesis of Alzheimer’s Disease.- 3.6. Systemic Changes in AD.- 3.7. The Pathological Changes of Parkinson’s Disease.- 4. Etiological Considerations.- 4.1. Genetic Factors.- 4.2. Environmental Factors.- 5. Relationships Between Aging and Neurodegenerative Disease.- 5.0. Introduction.- 5.1. Pathology in the Normal Elderly-Preclinical Disease?.- 5.2. Implications for Aging Research.- 5.3. The Concept of Normality.- 5.4. Relevance of Animal Studies.- 5.5. Aging and Disease—A Continuum.- 5.6. Genetic Susceptibility.- 5.7. Concluding Remarks.

Reviews

Author Information

Tab Content 6

Author Website:  

Customer Reviews

Recent Reviews

No review item found!

Add your own review!

Countries Available

All regions